Immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in healthy boys aged 10–18 years
T Petäjä, H Keränen, T Karppa, A Kawa… - Journal of Adolescent …, 2009 - Elsevier
PURPOSE: The human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine (Cervarix™)
has been shown to be well-tolerated and immunogenic in females aged 10 to 55 years, and …
has been shown to be well-tolerated and immunogenic in females aged 10 to 55 years, and …
Reduced-Antigen, Combined Diphtheria, Tetanus and Acellular Pertussis Vaccine, Adsorbed (Boostrix®) A Review of its Properties and Use as a Single-Dose Booster …
PL McCormack - Drugs, 2012 - Springer
Reduced-antigen, combined diphtheria, tetanus and three-component acellular pertussis
vaccine (Tdap; Boostrix®) is indicated for booster vaccination against diphtheria, tetanus …
vaccine (Tdap; Boostrix®) is indicated for booster vaccination against diphtheria, tetanus …
Vaccination of health care workers against pertussis: Meeting the need for safety within hospitals
U Heininger - Vaccine, 2014 - Elsevier
Pertussis outbreaks in hospitals are reason for substantial concern as they do cause
significant morbidity amongst patients and physical and emotional stress and absence from …
significant morbidity amongst patients and physical and emotional stress and absence from …
Immune responses in adults to revaccination with a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine 10 years after a previous dose
SA Halperin, D Scheifele, G De Serres, F Noya… - Vaccine, 2012 - Elsevier
BACKGROUND: Although decennial adult boosters of tetanus and diphtheria toxoids are
recommended in Canada and the United States, a second dose of pertussis vaccine during …
recommended in Canada and the United States, a second dose of pertussis vaccine during …
Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed …
BACKGROUND: Although decennial adult boosters of tetanus and diphtheria toxoids are
recommended in Canada and the United States, a second dose of pertussis vaccine is not …
recommended in Canada and the United States, a second dose of pertussis vaccine is not …
Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine coadministered with tetanus toxoid, reduced diphtheria toxoid, and acellular …
CM Wheeler, BM Harvey, ME Pichichero… - The Pediatric …, 2011 - journals.lww.com
Background: A combined immunization strategy for administration of human papillomavirus
(HPV) vaccine with other routine vaccines may lead to better compliance. Reactions and …
(HPV) vaccine with other routine vaccines may lead to better compliance. Reactions and …
Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine coadministered with combined diphtheria-tetanus-acellular …
J Garcia-Sicilia, TF Schwarz, A Carmona… - Journal of Adolescent …, 2010 - Elsevier
PURPOSE: Many countries recommend human papillomavirus (HPV) vaccination in female
adolescents at an age when other vaccines are routinely administered. This open …
adolescents at an age when other vaccines are routinely administered. This open …
Rate of recurrence of adverse events following immunization: results of 19 years of surveillance in Quebec, Canada
JG Zafack, E Toth, M Landry, JP Drolet… - The Pediatric …, 2019 - journals.lww.com
Background: While adverse events following immunization (AEFI) are frequent, there are
limited data on the safety of reimmunizing patients who had a prior AEFI. Our objective was …
limited data on the safety of reimmunizing patients who had a prior AEFI. Our objective was …
[PDF][PDF] Reducing the risk of pertussis in newborn infants
F Blangiardi, G Ferrera - J prev med hyg, 2009 - core.ac.uk
Pertussis (whooping cough) is a respiratory tract infection characterised by a paroxysmal
cough, caused by Bordetella pertussis, a gram negative coccobacillus. The disease can …
cough, caused by Bordetella pertussis, a gram negative coccobacillus. The disease can …
Combined, Reduced-Antigen Content Tetanus, Diphtheria, and Acellular Pertussis Vaccine (Boostrix®) A Review of its Use as a Single-Dose Booster Immunization in …
GL Plosker - BioDrugs, 2009 - Springer
Boostrix® is a three-pertussis component, combined, reduced-antigen content tetanus,
diphtheria, and acellular pertussis (Tdap) booster vaccine administered as a single …
diphtheria, and acellular pertussis (Tdap) booster vaccine administered as a single …